Roth Capital Starts Neurocrine Bio. (NBIX) at Buy
Get Alerts NBIX Hot Sheet
Price: $161.94 -1.81%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
Roth Capital initiates coverage on Neurocrine Bio. (NASDAQ: NBIX) with a Buy. PT $14.00.
For an analyst ratings summary and ratings history on Neurocrine Bio. click here. For more ratings news on Neurocrine Bio. click here.
Shares of Neurocrine Bio. closed at $7.38 yesterday.
For an analyst ratings summary and ratings history on Neurocrine Bio. click here. For more ratings news on Neurocrine Bio. click here.
Shares of Neurocrine Bio. closed at $7.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Craig-Hallum Starts Alterity Therapeutics (ATHE) at Buy
- CICC Starts Marriott International (MAR) at Outperform
- JPMorgan Resumes Take-Two Interactive (TTWO) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share